Skip to main content
Premium Trial:

Request an Annual Quote

AxCell to Market Protein Database

Premium

AxCell Biosciences, a subsidiary of Cytogen of Zurich, said it planned to begin marketing its database of protein interactions in early 2001, upon completing the mapping of the first one million protein interactions.

 

The company, which recently completed the first stage of its proteomics automation, said that over the next month it planned to measure 135,000 protein interactions. AxCell forecast that it would then be able to increase to 200,000 a month by mid-summer.

 

AxCell said it would be able to completely chart human protein signaling interactions in two to four years.

 

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.